Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived.
Aggregation-induced emission
Biomimetic nanoparticles
Erythrocyte
Photodynamic therapy
Safety assessment
Journal
Materials today. Bio
ISSN: 2590-0064
Titre abrégé: Mater Today Bio
Pays: England
ID NLM: 101757228
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
22
02
2022
revised:
22
04
2022
accepted:
02
05
2022
entrez:
23
5
2022
pubmed:
24
5
2022
medline:
24
5
2022
Statut:
epublish
Résumé
Erythrocytes are often used for the development of cell membrane camouflaged nanoparticles (NPs) due to their wide range of sources. However, whether the difference between autologous and allogeneic sources for the erythrocyte membranes have an influence on the performance of camouflaged NPs, which is still inconclusive. To this end, we developed two aggregation-induced emission (AIE) photosensitizers camouflaged with erythrocyte membranes (E-M), named E-M
Identifiants
pubmed: 35601893
doi: 10.1016/j.mtbio.2022.100279
pii: S2590-0064(22)00077-1
pmc: PMC9119842
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100279Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Bioact Mater. 2021 Apr 15;6(11):3904-3923
pubmed: 33997485
Adv Mater. 2013 Jul 12;25(26):3549-53
pubmed: 23712782
Proc Natl Acad Sci U S A. 2021 Jul 27;118(30):
pubmed: 34301864
Adv Mater. 2021 Aug;33(33):e2102322
pubmed: 34247428
Nano Lett. 2020 Jul 8;20(7):5228-5235
pubmed: 32510963
Adv Mater. 2019 Jun;31(24):e1900927
pubmed: 31012164
J Control Release. 2015 Dec 28;220(Pt B):600-7
pubmed: 26210440
Adv Mater. 2019 Dec;31(51):e1904639
pubmed: 31692128
Adv Mater. 2021 Jan;33(4):e2007247
pubmed: 33306220
Adv Mater. 2021 Dec;33(50):e2100241
pubmed: 34121236
Angew Chem Int Ed Engl. 2021 Aug 23;60(35):19355-19363
pubmed: 34105217
ACS Nano. 2019 Jun 25;13(6):7209-7215
pubmed: 31117372
Acc Chem Res. 2018 Jun 19;51(6):1404-1414
pubmed: 29733571
Adv Healthc Mater. 2021 Jul;10(13):e2100311
pubmed: 33963820
ACS Nano. 2016 Mar 22;10(3):3267-81
pubmed: 26855010
ACS Appl Mater Interfaces. 2020 Dec 23;12(51):56767-56781
pubmed: 33289550
Int J Nanomedicine. 2020 Mar 19;15:1915-1928
pubmed: 32256068
J Control Release. 2021 Sep 10;337:90-104
pubmed: 34274385
Anal Chem. 2021 Jan 19;93(2):1033-1042
pubmed: 33296189
Biomaterials. 2020 Oct;257:120256
pubmed: 32736263
ACS Nano. 2019 Mar 26;13(3):2849-2857
pubmed: 30803232
Adv Healthc Mater. 2021 Dec;10(24):e2100945
pubmed: 34418321
Bioact Mater. 2021 Jan 23;6(8):2291-2302
pubmed: 33553816
Sci Adv. 2019 Oct 23;5(10):eaaw6870
pubmed: 31681841
Angew Chem Int Ed Engl. 2022 Jun 13;61(24):e202203115
pubmed: 35395111
Theranostics. 2021 Jan 27;11(8):3710-3724
pubmed: 33664857
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):968-979
pubmed: 30880468
Acc Chem Res. 2019 Nov 19;52(11):3064-3074
pubmed: 31657899
Biomater Res. 2021 Apr 1;25(1):8
pubmed: 33795019
Bioact Mater. 2021 May 01;6(12):4402-4414
pubmed: 33997516
Natl Sci Rev. 2021 Mar 03;8(6):nwab039
pubmed: 34691671
Small. 2020 Jun;16(22):e2001704
pubmed: 32338436
Adv Colloid Interface Sci. 2021 Aug;294:102451
pubmed: 34098385
ACS Nano. 2019 Dec 24;13(12):13985-13994
pubmed: 31833366
Pharmaceutics. 2021 Jan 14;13(1):
pubmed: 33466655
Biosens Bioelectron. 2021 Aug 1;185:113267
pubmed: 33933909
Small Struct. 2020 Oct;1(1):
pubmed: 33817693
Adv Mater. 2022 Jan 22;:e2109609
pubmed: 35064993
ACS Nano. 2020 Nov 9;:
pubmed: 33166111
Int J Nanomedicine. 2020 Apr 23;15:2873-2884
pubmed: 32368059
Angew Chem Int Ed Engl. 2020 Jun 22;59(26):10461-10465
pubmed: 32203634
ACS Nano. 2020 Sep 22;14(9):11452-11462
pubmed: 32820907
ACS Nano. 2020 Apr 28;14(4):4014-4026
pubmed: 32212674
ACS Nano. 2018 Feb 27;12(2):1630-1641
pubmed: 29346736
Int J Nanomedicine. 2019 Jun 17;14:4431-4448
pubmed: 31354269
Adv Drug Deliv Rev. 2021 Mar;170:312-339
pubmed: 32946921
Pharmaceutics. 2019 Dec 24;12(1):
pubmed: 31878155
Nat Nanotechnol. 2013 May;8(5):336-40
pubmed: 23584215
J Control Release. 2021 Jul 10;335:345-358
pubmed: 34029633
Biomaterials. 2016 May;89:89-97
pubmed: 26950168
Nat Rev Clin Oncol. 2020 Nov;17(11):657-674
pubmed: 32699309
Adv Healthc Mater. 2021 Dec;10(24):e2101036
pubmed: 34414687
J Med Chem. 2020 Mar 12;63(5):1996-2012
pubmed: 32039596
Sci Adv. 2020 Apr 15;6(16):eaay9035
pubmed: 32490199
Signal Transduct Target Ther. 2021 Mar 19;6(1):122
pubmed: 33737507
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):10980-5
pubmed: 21690347
Bioact Mater. 2021 Mar 01;6(9):2956-2968
pubmed: 33732966
Drug Deliv. 2019 Dec;26(1):199-207
pubmed: 30835586
Clin Transl Med. 2021 Feb;11(2):e292
pubmed: 33635002
Methods. 2020 May 1;177:2-14
pubmed: 31874237
J Nanobiotechnology. 2020 Jul 20;18(1):101
pubmed: 32690018
Adv Mater. 2017 Sep;29(35):
pubmed: 28722140
Adv Healthc Mater. 2021 Jun;10(11):e2002153
pubmed: 33829678
Adv Mater. 2019 Mar;31(12):e1807888
pubmed: 30730070
Biomaterials. 2021 Aug;275:120979
pubmed: 34166910
Acta Pharm Sin B. 2018 Jan;8(1):14-22
pubmed: 29872619
Theranostics. 2017 Jun 25;7(10):2575-2592
pubmed: 28819448
Biomaterials. 2022 Apr;283:121449
pubmed: 35247637
ACS Appl Mater Interfaces. 2021 Jun 2;13(21):24532-24542
pubmed: 34019368
Molecules. 2021 Jan 07;26(2):
pubmed: 33430513
Small. 2019 Jan;15(1):e1804105
pubmed: 30457701
Nanomicro Lett. 2020 Apr 20;12(1):94
pubmed: 34138120